|
2024-02-15 |
2024-02-15 |
A
Achat
|
ARMEN GARO H
See Remarks
Administrateur exécutif
|
500 000
+396.9%
0,65
324 050 USD
|
500 000
+396.9%
|
0,65
|
324 050 USD
|
|
|
2023-11-17 |
2023-11-15 |
A
Achat
|
WIINBERG ULF
Administrateur non-exécutif
|
25 000
+25.2%
0,76
19 000 USD
|
25 000
+25.2%
|
0,76
|
19 000 USD
|
|
|
2022-01-06 |
2022-01-06 |
V
Vente
|
O'Day Steven J
Chief Medical Officer
Dirigeant
|
38 679
-38.7%
3,06
118 346 USD
|
38 679
-38.7%
|
3,06
|
118 346 USD
|
|
|
2021-09-14 |
2021-09-13 |
V
Vente
|
ARMEN GARO H
Chairman and CEO
Administrateur exécutif
|
82 107
-9.6%
6,50
533 696 USD
|
82 107
-9.6%
|
6,50
|
533 696 USD
|
|
|
2021-09-14 |
2021-09-10 |
V
Vente
|
KLASKIN CHRISTINE M
PFO & PAO
Dirigeant
|
11 120
-10.7%
6,50
72 280 USD
|
11 120
-10.7%
|
6,50
|
72 280 USD
|
|
|
2020-06-18 |
2020-06-17 |
V
Vente
|
INCYTE CORP
Actionnaire important
|
141 920
-0.8%
3,66
518 831 USD
|
141 920
-0.8%
|
3,66
|
518 831 USD
|
|
|
2020-06-18 |
2020-06-16 |
V
Vente
|
INCYTE CORP
Actionnaire important
|
72 080
-0.4%
3,66
264 007 USD
|
72 080
-0.4%
|
3,66
|
264 007 USD
|
|
|
2020-06-15 |
2020-06-15 |
V
Vente
|
INCYTE CORP
Actionnaire important
|
384 025
-2.2%
3,57
1 372 160 USD
|
384 025
-2.2%
|
3,57
|
1 372 160 USD
|
|
|
2020-06-15 |
2020-06-12 |
V
Vente
|
INCYTE CORP
Actionnaire important
|
9 100
-0.1%
3,58
32 556 USD
|
9 100
-0.1%
|
3,58
|
32 556 USD
|
|
|
2020-06-15 |
2020-06-11 |
V
Vente
|
INCYTE CORP
Actionnaire important
|
183 875
-1.0%
3,77
692 786 USD
|
183 875
-1.0%
|
3,77
|
692 786 USD
|
|
|
2017-12-14 |
2017-12-12 |
V
Vente
|
Baysal Ozer
Chief Commercial Officer
|
3 712
-5.9%
3,46
12 846 USD
|
3 712
-5.9%
|
3,46
|
12 846 USD
|
|
|
2017-12-14 |
2017-12-12 |
V
Vente
|
Valentine Karen
Chief Legal Officer
|
8 358
-7.6%
3,46
28 921 USD
|
8 358
-7.6%
|
3,46
|
28 921 USD
|
|
|
2017-12-14 |
2017-12-12 |
V
Vente
|
Duncan Alex
Chief Technology Officer
|
6 546
-23.7%
3,46
22 651 USD
|
6 546
-23.7%
|
3,46
|
22 651 USD
|
|
|
2017-12-14 |
2017-12-12 |
V
Vente
|
Buell Jennifer
Chief Communications Officer
|
3 511
-9.0%
3,46
12 152 USD
|
3 511
-9.0%
|
3,46
|
12 152 USD
|
|
|
2017-12-14 |
2017-12-12 |
V
Vente
|
KLASKIN CHRISTINE M
VP, Finance
|
5 610
-8.0%
3,46
19 418 USD
|
5 610
-8.0%
|
3,46
|
19 418 USD
|
|
|
2017-04-12 |
2017-04-12 |
A
Achat
|
ARMEN GARO H
Chairman & CEO
Administrateur exécutif
|
29 456
+2.1%
3,29
97 055 USD
|
29 456
+2.1%
|
3,29
|
97 055 USD
|
|
|
2017-04-12 |
2017-04-10 |
A
Achat
|
ARMEN GARO H
Chairman & CEO
Administrateur exécutif
|
70 544
+5.4%
3,37
237 465 USD
|
70 544
+5.4%
|
3,37
|
237 465 USD
|
|
|
2017-02-14 |
2017-02-14 |
A
Achat
|
INCYTE CORP
Actionnaire important
|
10 000 000
+128.8%
6,00
60 000 000 USD
|
10 000 000
+128.8%
|
6,00
|
60 000 000 USD
|
|
|
2016-09-08 |
2016-09-06 |
A
Achat
|
WIINBERG ULF
Administrateur non-exécutif
|
30 000
+inf%
6,29
188 700 USD
|
30 000
+inf%
|
6,29
|
188 700 USD
|
|
|
2016-05-10 |
2016-05-09 |
A
Achat
|
ARMEN GARO H
Chairman & CEO
Dirigeant
|
50 000
+3.7%
3,28
163 935 USD
|
50 000
+3.7%
|
3,28
|
163 935 USD
|
|
|
2016-05-10 |
2016-05-05 |
A
Achat
|
ARMEN GARO H
Chairman & CEO
Dirigeant
|
50 000
+3.9%
3,08
153 960 USD
|
50 000
+3.9%
|
3,08
|
153 960 USD
|
|
|
2016-05-09 |
2016-05-05 |
A
Achat
|
Baysal Ozer
Chief Business Officer
Dirigeant
|
2 250
+7.2%
3,10
6 975 USD
|
2 250
+7.2%
|
3,10
|
6 975 USD
|
|
|
2016-03-08 |
2016-03-07 |
A
Achat
|
ARMEN GARO H
Chairman & CEO
Dirigeant
|
200 000
+19.0%
4,03
805 600 USD
|
200 000
+19.0%
|
4,03
|
805 600 USD
|
|
|
2015-12-30 |
2015-12-29 |
V
Vente
|
ARMEN GARO H
Chairman & CEO
Dirigeant
|
85 224
-6.6%
4,57
389 602 USD
|
85 224
-6.6%
|
4,57
|
389 602 USD
|
|
|
2015-12-30 |
2015-12-28 |
V
Vente
|
ARMEN GARO H
Chairman & CEO
Dirigeant
|
89 917
-6.5%
4,59
413 142 USD
|
89 917
-6.5%
|
4,59
|
413 142 USD
|
|
|
2015-12-30 |
2015-12-28 |
V
Vente
|
ARMEN GARO H
Chairman & CEO
Dirigeant
|
44 435
-3.1%
4,62
205 134 USD
|
44 435
-3.1%
|
4,62
|
205 134 USD
|
|
|
2015-09-29 |
2015-09-25 |
A
Achat
|
ARMEN GARO H
Chairman & CEO
Dirigeant
|
100 000
+7.6%
5,03
503 000 USD
|
100 000
+7.6%
|
5,03
|
503 000 USD
|
|
|
2015-09-29 |
2015-09-25 |
A
Achat
|
Ballantyne Charles Evan
Chief Financial Officer
Dirigeant
|
10 000
+inf%
5,05
50 500 USD
|
10 000
+inf%
|
5,05
|
50 500 USD
|
|
|
2015-04-30 |
2015-04-29 |
V
Vente
|
Malik Shahzad
Administrateur non-exécutif
|
407 377
-100.0%
7,02
2 858 809 USD
|
407 377
-100.0%
|
7,02
|
2 858 809 USD
|
|
|
2015-04-30 |
2015-04-28 |
V
Vente
|
Malik Shahzad
Administrateur non-exécutif
|
700 000
-63.2%
7,16
5 012 560 USD
|
700 000
-63.2%
|
7,16
|
5 012 560 USD
|
|
|
2015-01-13 |
2015-01-09 |
V
Vente
|
QVT Associates GP LLC
Actionnaire important
|
41 830
-0.6%
5,33
222 954 USD
|
41 830
-0.6%
|
5,33
|
222 954 USD
|
|
|
2015-01-13 |
2015-01-09 |
V
Vente
|
QVT Associates GP LLC
Actionnaire important
|
83 100
-1.2%
5,31
441 261 USD
|
83 100
-1.2%
|
5,31
|
441 261 USD
|
|
|
2015-01-13 |
2015-01-09 |
V
Vente
|
QVT Associates GP LLC
Actionnaire important
|
100 000
-1.4%
5,35
535 000 USD
|
100 000
-1.4%
|
5,35
|
535 000 USD
|
|
|
2015-01-13 |
2015-01-09 |
V
Vente
|
QVT Associates GP LLC
Actionnaire important
|
89 800
-1.2%
5,49
493 002 USD
|
89 800
-1.2%
|
5,49
|
493 002 USD
|
|
|
2015-01-13 |
2015-01-09 |
V
Vente
|
QVT Associates GP LLC
Actionnaire important
|
50 000
-0.7%
5,44
272 000 USD
|
50 000
-0.7%
|
5,44
|
272 000 USD
|
|
|
2015-01-13 |
2015-01-09 |
V
Vente
|
QVT Associates GP LLC
Actionnaire important
|
100 000
-1.4%
5,20
520 000 USD
|
100 000
-1.4%
|
5,20
|
520 000 USD
|
|
|
2015-01-13 |
2015-01-09 |
V
Vente
|
QVT Associates GP LLC
Actionnaire important
|
43 080
-0.6%
5,57
239 956 USD
|
43 080
-0.6%
|
5,57
|
239 956 USD
|
|
|
2015-01-13 |
2015-01-09 |
V
Vente
|
QVT Associates GP LLC
Actionnaire important
|
856 920
-10.3%
5,18
4 438 846 USD
|
856 920
-10.3%
|
5,18
|
4 438 846 USD
|
|
|
2015-01-13 |
2015-01-09 |
V
Vente
|
QVT Associates GP LLC
Actionnaire important
|
215 000
-2.5%
5,19
1 115 850 USD
|
215 000
-2.5%
|
5,19
|
1 115 850 USD
|
|
|
2015-01-13 |
2015-01-09 |
V
Vente
|
QVT Associates GP LLC
Actionnaire important
|
400 000
-4.5%
5,62
2 248 000 USD
|
400 000
-4.5%
|
5,62
|
2 248 000 USD
|
|
|
2015-01-13 |
2015-01-09 |
V
Vente
|
QVT Associates GP LLC
Actionnaire important
|
53 606
-0.6%
5,21
279 287 USD
|
53 606
-0.6%
|
5,21
|
279 287 USD
|
|
|
2015-01-13 |
2015-01-09 |
V
Vente
|
QVT Associates GP LLC
Actionnaire important
|
146 394
-1.6%
5,27
771 496 USD
|
146 394
-1.6%
|
5,27
|
771 496 USD
|
|
|
2015-01-13 |
2015-01-09 |
V
Vente
|
QVT Associates GP LLC
Actionnaire important
|
143 900
-1.6%
5,30
762 670 USD
|
143 900
-1.6%
|
5,30
|
762 670 USD
|
|
|
2015-01-13 |
2015-01-09 |
V
Vente
|
QVT Associates GP LLC
Actionnaire important
|
20 000
-0.2%
5,55
111 000 USD
|
20 000
-0.2%
|
5,55
|
111 000 USD
|
|
|
2011-12-29 |
2011-12-29 |
V
Vente
|
Wentworth Kerry
VP, Clinical, Reg, & Quality
Dirigeant
|
8 939
-36.6%
2,01
17 967 USD
|
8 939
-36.6%
|
2,01
|
17 967 USD
|
|
|
2011-12-29 |
2011-12-29 |
V
Vente
|
Valentine Karen
VP, General Counsel
Dirigeant
|
7 605
-86.5%
1,98
15 058 USD
|
7 605
-86.5%
|
1,98
|
15 058 USD
|
|
|
2011-12-29 |
2011-12-28 |
V
Vente
|
Sharp Shalini
CFO
Dirigeant
|
1 711
-3.9%
2,09
3 576 USD
|
1 711
-3.9%
|
2,09
|
3 576 USD
|
|
|
2011-12-29 |
2011-12-28 |
V
Vente
|
Wentworth Kerry
VP, Clinical, Reg, & Quality
Dirigeant
|
1 893
-7.2%
2,09
3 956 USD
|
1 893
-7.2%
|
2,09
|
3 956 USD
|
|
|
2011-12-29 |
2011-12-28 |
V
Vente
|
Valentine Karen
VP, General Counsel
Dirigeant
|
1 301
-12.9%
2,09
2 719 USD
|
1 301
-12.9%
|
2,09
|
2 719 USD
|
|
|
2011-12-29 |
2011-12-27 |
V
Vente
|
Sharp Shalini
CFO
Dirigeant
|
2 853
-6.2%
2,14
6 105 USD
|
2 853
-6.2%
|
2,14
|
6 105 USD
|
|
|
2011-12-29 |
2011-12-27 |
V
Vente
|
KLASKIN CHRISTINE M
VP, Finance
Dirigeant
|
1 824
-12.6%
2,14
3 903 USD
|
1 824
-12.6%
|
2,14
|
3 903 USD
|
|
|
2011-12-29 |
2011-12-27 |
V
Vente
|
Wentworth Kerry
VP, Clinical, Reg, & Quality
Dirigeant
|
3 156
-10.7%
2,14
6 754 USD
|
3 156
-10.7%
|
2,14
|
6 754 USD
|
|
|
2011-12-29 |
2011-12-27 |
V
Vente
|
Valentine Karen
VP, General Counsel
Dirigeant
|
2 169
-17.7%
2,14
4 642 USD
|
2 169
-17.7%
|
2,14
|
4 642 USD
|
|
|
2011-12-23 |
2011-12-23 |
V
Vente
|
KLASKIN CHRISTINE M
VP Finance
Dirigeant
|
511
-3.4%
2,20
1 123 USD
|
511
-3.4%
|
2,20
|
1 123 USD
|
|
|
2011-12-23 |
2011-12-23 |
V
Vente
|
Wentworth Kerry
VP, Clinical, Reg, & Quality
Dirigeant
|
886
-2.9%
2,20
1 947 USD
|
886
-2.9%
|
2,20
|
1 947 USD
|
|
|
2011-12-23 |
2011-12-23 |
V
Vente
|
Valentine Karen
VP, General Counsel
Dirigeant
|
608
-4.7%
2,20
1 336 USD
|
608
-4.7%
|
2,20
|
1 336 USD
|
|
|
2011-12-23 |
2011-12-23 |
V
Vente
|
Sharp Shalini
CFO
Dirigeant
|
795
-1.7%
2,20
1 747 USD
|
795
-1.7%
|
2,20
|
1 747 USD
|
|
|
2011-12-23 |
2011-12-22 |
V
Vente
|
KLASKIN CHRISTINE M
VP Finance
Dirigeant
|
993
-6.2%
2,19
2 175 USD
|
993
-6.2%
|
2,19
|
2 175 USD
|
|
|
2011-12-23 |
2011-12-22 |
V
Vente
|
Wentworth Kerry
VP, Clinical, Reg, & Quality
Dirigeant
|
1 716
-5.4%
2,19
3 759 USD
|
1 716
-5.4%
|
2,19
|
3 759 USD
|
|
|
2011-12-23 |
2011-12-22 |
V
Vente
|
Valentine Karen
VP, General Counsel
Dirigeant
|
1 177
-8.4%
2,19
2 578 USD
|
1 177
-8.4%
|
2,19
|
2 578 USD
|
|
|
2011-12-23 |
2011-12-22 |
V
Vente
|
Sharp Shalini
CFO
Dirigeant
|
1 548
-3.2%
2,19
3 391 USD
|
1 548
-3.2%
|
2,19
|
3 391 USD
|
|
|
2011-12-23 |
2011-12-21 |
V
Vente
|
KLASKIN CHRISTINE M
VP Finance
Dirigeant
|
1 975
-11.0%
2,24
4 420 USD
|
1 975
-11.0%
|
2,24
|
4 420 USD
|
|
|
2011-12-23 |
2011-12-21 |
V
Vente
|
Wentworth Kerry
VP, Clinical, Reg, & Quality
Dirigeant
|
3 414
-9.6%
2,24
7 641 USD
|
3 414
-9.6%
|
2,24
|
7 641 USD
|
|
|
2011-12-23 |
2011-12-21 |
V
Vente
|
Valentine Karen
VP, General Counsel
Dirigeant
|
2 348
-14.3%
2,24
5 255 USD
|
2 348
-14.3%
|
2,24
|
5 255 USD
|
|
|
2011-12-23 |
2011-12-21 |
V
Vente
|
Sharp Shalini
CFO
Dirigeant
|
3 087
-6.0%
2,24
6 909 USD
|
3 087
-6.0%
|
2,24
|
6 909 USD
|
|
|
2011-10-03 |
2011-09-30 |
A
Achat
|
ARMEN GARO H
Chairman & CEO
Dirigeant
|
16 666
+1.9%
2,99
49 768 USD
|
16 666
+1.9%
|
2,99
|
49 768 USD
|
|
|
2011-08-17 |
2011-08-16 |
A
Achat
|
ARMEN GARO H
Chairman & CEO
Dirigeant
|
2 150 976
+67.7%
0,51
1 096 998 USD
|
2 150 976
+67.7%
|
0,51
|
1 096 998 USD
|
|
|
2010-05-19 |
2010-05-18 |
A
Achat
|
Wright Timothy
Administrateur non-exécutif
|
10 000
+inf%
1,34
13 400 USD
|
10 000
+inf%
|
1,34
|
13 400 USD
|
|
|
2010-03-18 |
2010-03-16 |
V
Vente
|
Valentine Karen
VP and General Counsel
Dirigeant
|
29 039
-36.1%
0,76
22 006 USD
|
29 039
-36.1%
|
0,76
|
22 006 USD
|
|
|
2009-06-29 |
2009-06-25 |
A
Achat
|
ARMEN GARO H
Chairman & CEO
Dirigeant
|
25 000
+2.2%
1,97
49 250 USD
|
25 000
+2.2%
|
1,97
|
49 250 USD
|
|
|
2009-02-25 |
2009-02-25 |
A
Achat
|
HATSOPOULOS JOHN
Administrateur non-exécutif
|
10 000
+22.2%
0,37
3 700 USD
|
10 000
+22.2%
|
0,37
|
3 700 USD
|
|
|
2008-09-05 |
2008-09-04 |
A
Achat
|
HATSOPOULOS JOHN
Administrateur non-exécutif
|
3 000
+7.1%
1,72
5 160 USD
|
3 000
+7.1%
|
1,72
|
5 160 USD
|
|
|
2008-09-05 |
2008-09-03 |
A
Achat
|
HATSOPOULOS JOHN
Administrateur non-exécutif
|
7 000
+20.0%
1,71
11 970 USD
|
7 000
+20.0%
|
1,71
|
11 970 USD
|
|
|
2008-05-20 |
2008-05-16 |
A
Achat
|
MARGARET EISEN
Administrateur non-exécutif
|
15 000
+300.0%
2,36
35 348 USD
|
15 000
+300.0%
|
2,36
|
35 348 USD
|
|
|
2008-01-11 |
2008-01-09 |
A
Achat
|
ARMEN GARO H
Chairman and CEO
Dirigeant
|
1 166 667
+10.2%
3,00
3 500 001 USD
|
1 166 667
+10.2%
|
3,00
|
3 500 001 USD
|
|
